Personalized Vitamin D Supplementation Systems

Publication ID: 24-11857557_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Personalized Vitamin D Supplementation Systems,” Published Technical Disclosure No. 24-11857557_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857557_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,557.

Summary of the Inventive Concept

A synergistic combination of oral dissolvable films, IoT devices, AI, blockchain, and new materials to create personalized vitamin D supplementation systems, enhancing user experience, and ensuring authenticity, quality, and efficacy.

Background and Problem Solved

The original patent disclosed an oral dissolvable film containing vitamin D3, which, although effective, lacks personalized dosing regimens and real-time monitoring capabilities. The new inventive concept addresses these limitations by integrating the oral dissolvable film with cutting-edge technologies, providing a more comprehensive and effective vitamin D supplementation solution.

Detailed Description of the Inventive Concept

The new inventive concept combines the oral dissolvable film containing vitamin D3 with a wearable IoT device that tracks user-specific biometric data, such as skin tone, dietary habits, and sun exposure. An AI-powered recommendation engine analyzes this data to suggest customized dosing regimens, ensuring optimal vitamin D levels. Additionally, blockchain technology is employed to track and verify the film's authenticity, quality, and storage conditions, guaranteeing a secure and reliable supply chain. The system may also incorporate advanced materials, such as graphene-based layers, to enhance the film's stability and controlled release of the active ingredient.

Novelty and Inventive Step

The new inventive concept's novelty lies in the synergistic integration of distinct technologies, creating a personalized vitamin D supplementation system that is more effective, efficient, and secure than existing solutions. The inventive step is the combination of these technologies to provide a holistic approach to vitamin D supplementation, overcoming the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different IoT devices, such as smartwatches or mobile apps, or the incorporation of additional sensors to track other health metrics. Variations may also involve different blockchain platforms or the use of other advanced materials to enhance the oral dissolvable film's properties.

Potential Commercial Applications and Market

The personalized vitamin D supplementation system has significant commercial potential in the healthcare and wellness industries, particularly in the context of preventative medicine and personalized nutrition. The market for such a system is substantial, with potential applications in hospitals, clinics, and retail settings.

Field of Art

Pharmaceutical drug delivery systems, specifically oral dissolvable film (ODF) technologies for vitamin and nutritional supplements, requiring expertise in pharmaceutical formulation, materials science, and drug delivery mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree (MS/PhD) in pharmaceutical sciences or chemical engineering, experienced in drug formulation, materials characterization, and understanding of bioavailability and delivery mechanisms

Obviousness Rationale

A PHOSITA would recognize that integrating digital tracking, AI recommendation, and blockchain technologies with the existing oral dissolvable film (ODF) vitamin D3 delivery system represents a predictable combination of known techniques in pharmaceutical personalization and supply chain management. The core ODF technology remains fundamentally unchanged, with added technological layers providing enhanced monitoring and customization. These extensions represent logical technological progressions that would be obvious to implement given the existing patent's foundational ODF design.

Obvious Combinations & Variations

Source Patent Element
Oral dissolvable film containing vitamin D3 with specific composition of water, sodium carboxymethyl cellulose, and polyvinylpyrrolidone
PTD Variation
Adding graphene-based layer to enhance film stability and controlled ingredient release
Obviousness Reasoning
Material science techniques for enhancing pharmaceutical film stability are well-established, and graphene's properties are known for improving mechanical and barrier characteristics in drug delivery systems
Source Patent Element
Method of delivering cholecalciferol enterally via dissolving film
PTD Variation
Incorporating IoT device and AI-powered recommendation engine for personalized dosing
Obviousness Reasoning
Personalized medicine approaches using digital tracking and algorithmic dosing recommendations are standard practice in contemporary healthcare technology
Source Patent Element
Oral film designed to prevent or treat vitamin D deficiency
PTD Variation
Blockchain-enabled authentication and supply chain tracking of pharmaceutical product
Obviousness Reasoning
Supply chain authentication technologies are increasingly common in pharmaceutical industries, representing a predictable technological extension for ensuring product integrity
Source Patent Element
Vitamin D3 delivery via dissolving film
PTD Variation
Smart packaging with sensor layers detecting moisture and oxygen exposure
Obviousness Reasoning
Sensor-based monitoring of pharmaceutical storage conditions is a known technique for ensuring product quality and stability in sensitive formulations
Source Patent Element
Oral dissolvable film with specific compositional parameters
PTD Variation
Decentralized platform connecting manufacturers, distributors, and healthcare providers
Obviousness Reasoning
Digital platforms facilitating pharmaceutical supply chain interactions are standard technological developments in modern healthcare ecosystems
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857557 for oral dissolvable vitamin D3 films, the present publication demonstrates that the combination of digital tracking, AI recommendation, blockchain authentication, and advanced material technologies represents an obvious extension of the foundational pharmaceutical delivery system. A person having ordinary skill in the art would readily recognize these technological integrations as predictable variations that do not require inventive complexity beyond standard pharmaceutical and digital health innovations.

Original Patent Information

Patent NumberUS 11,857,557
TitleOral dissolvable film containing vitamin D3